Analyst Price Targets — OMCL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 6, 2026 11:55 am | — | Piper Sandler | $49.00 | $39.08 | TheFly | Omnicell price target lowered to $49 from $63 at Piper Sandler |
| January 16, 2026 10:15 am | — | UBS | $53.00 | $50.98 | StreetInsider | Omnicell (OMCL) PT Raised to $53 at BofA Securities |
| January 7, 2026 10:47 pm | — | KeyBanc | $60.00 | $47.45 | TheFly | Omnicell upgraded to Overweight from Sector Weight at KeyBanc |
| January 5, 2026 1:08 pm | — | Wells Fargo | $52.00 | $45.64 | TheFly | Omnicell price target raised to $52 from $43 at Wells Fargo |
| August 11, 2025 12:26 pm | Jessica Tassan | Piper Sandler | $55.00 | $31.11 | StreetInsider | Omnicell (OMCL) PT Lowered to $55 at Piper Sandler Despite Guide Raise |
| May 14, 2025 10:48 am | Stan Berenshteyn | Wells Fargo | $35.00 | $27.46 | TheFly | Omnicell upgraded to Overweight from Equal Weight at Wells Fargo |
| January 13, 2025 11:06 am | Stan Berenshteyn | Wells Fargo | $40.00 | $43.37 | TheFly | Omnicell price target lowered to $40 from $49 at Wells Fargo |
| October 31, 2024 6:01 am | Stephanie Davis | Barclays | $58.00 | $53.05 | TheFly | Omnicell price target raised to $58 from $39 at Barclays |
| August 5, 2024 4:02 pm | Sean Wieland | Piper Sandler | $61.00 | $40.00 | StreetInsider | Omnicell (OMCL) PT Raised to $61 at Piper Sandler |
| August 2, 2024 3:44 am | Stephanie Davis | Barclays | $39.00 | $39.22 | StreetInsider | Barclays Upgrades Omnicell (OMCL) to Equalweight |
Latest News for OMCL
Omnicell, Inc. (NASDAQ: OMCL - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have issued a buy recommendation on the company. The
Hillsdale Investment Management Inc. boosted its position in Omnicell, Inc. (NASDAQ: OMCL) by 40.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 144,427 shares of the company's stock after acquiring an additional 41,500 shares during the period. Hillsdale Investment
Shares of Omnicell, Inc. (NASDAQ: OMCL - Get Free Report) gapped down before the market opened on Thursday following a dissappointing earnings announcement. The stock had previously closed at $46.69, but opened at $39.69. Omnicell shares last traded at $38.38, with a volume of 552,117 shares changing hands. The company reported $0.40 earnings per share for
Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
Omnicell (OMCL) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.6 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.